← Current Drug Targets - Immune Endocrine & Metabolic Disorders
Papers in Current Drug Targets - Immune Endocrine & Metabolic Disorders
Page 2 · newest first
- Studies on Human Neutrophil Biological Functions by Means of Formylpeptide Receptor Agonists and AntagonistsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2003
- Unfolding the Pathophysiological Role of Bioactive LysophospholipidsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2003
- Controlled Modulation of Inflammatory, Stress and Apoptotic Responses in MacrophagesCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2003
- Vaccination Against Leishmania InfectionsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Molecular and Cellular Tools in Human Cystic EchinococcosisCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Prospects for A Human Toxoplasma VaccineCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 DiabetesCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Apoptotic Cell Death in Renal Injury: The Rationale for InterventionCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic β Cell Function: Potential Therapeutic ImplicationsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Common Treatment of Polycystic Ovarian Syndrome and Major Depressive Disorder: Case Report and ReviewCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Cell Cycle Dysregulation During Hiv Infection: Perspectives of a Target Based TherapyCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Cell Cycle Dysregulation During Hiv Infection: Perspectives of a Target Based TherapyCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2002
- Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin ResistanceCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- A New Molecular Target of Insulin Action: Regulating the Pivotal PDK1Current Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Immune Responses to Fungal Infections and Therapeutic ImplicationsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Cytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A ReviewCytomegalovirus Infection in Immunocompetent and Immunocompromised Individuals - A ReviewCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Molecular Basis for Designing Selective Modulators of Retinoic Acid Receptor Transcriptional ActivitiesCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Mechanisms of Interferon Mediated Anti-Viral ResistanceCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Metastatic Thyroid Cancer Unresponsive to Conventional Therapies: Novel Management Approaches Through Translational Clinical ResearchCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Estrogens and Colorectal CancerCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Treatment of Rheumatoid Arthritis New Therapeutic Approaches with Biological AgentsCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Plasmid DNA VaccinesCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001
- Advances in the Treatment of OsteoporosisCurrent Drug Targets - Immune Endocrine & Metabolic Disorders · 2001